Skip to main content

Table 1 Demographic comparison of HIV-infected subjects who were positive or negative for the HLA-B*57:01 allele

From: HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects

HIV-1-Infected Subjects Screening Population HLA-B*57:01 Positive (n = 13) Screening Population HLA-B*57:01 Negative (n = 372) Total Enrolled Population HLA-B*57:01 Negative (N = 296)
Median Age (range) 42 (26–62) 44 (19–70) 43.5 (20–68)
Male, n (%) 9 (69%) 298 (80%) 234 (79%)
Race
 African-American/African Heritage, n (%) 2 (15%) 132 (35%) 102 (34%)
 White, n (%) 11 (85%) 216 (58%) 177 (60%)
 Asian/Other, n (%) 0 24 (6%) 17 (6%)
Ethnicity
 Hispanic/Latino, n (%) 2 (15%) 88 (24%) 77 (26%)
Median CD4 cells/mm3 (range) based on Day 1 values 321 (129–984) 482 (19–1553) 489.5 (77–1479)a
  1. aThis difference was not statistically significant (P = 0.0695, Wilcoxon rank sum test)